Linda Qu: Delighted to invite Stergios Boussios and Saak Ovsepian as guest editors for a special issue in Oncology Research
Linda Qu, Development Editor of Oncology at Tech Science Press, shared a post on LinkedIn:
“New Special Issue Call For Paper – Molecular Mechanisms and Precision Therapeutics in Urological Cancers: a Focus on Prostate and Renal Cell Cancer
We are delighted to invite Professor Stergios Boussios and Saak Ovsepian, as our guest editors for this special issue in Oncology Research, published under Tech Science Press. This special issue aims to provide a comprehensive understanding of the molecular mechanisms underlying prostate cancer and RCC, highlight recent discoveries, and explore potential avenues for personalized treatment strategies.
This collection will explore the latest advancements in prostate and renal cell cancer, covering but not limited to:
- Genetic and Epigenetic Alterations in Prostate Cancer and RCC
- Biomarkers for Early Detection, Prognosis and Therapy Response
- Mechanisms of Resistance to VEGF, mTOR and RAF Kinase Inhibitors
- Strategies to Overcome Drug Resistance in Urological Cancers
- Personalized Treatment Approaches in Prostate Cancer and RCC
- Advances in Immunotherapy, Checkpoint Inhibitors and Small Molecules
- Role of the Microenvironment in Cancer Growth and Metastasis
- Interplay Between Molecular Pathways and Treatment Response
- Preclinical and Clinical Studies on Novel Treatment Strategies
- Biomarker-Driven Clinical Trials in Urological Cancers
Guest Editors: Stergios Boussios and Saak Ovsepian
Submission Deadline: 31 December 2025
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023